Clinical Trial Update: Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies [Phase 3]

View source ↗

Summary

Phase 3 efficacy study evaluates a ragweed sublingual immunotherapy product for allergic rhinitis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Ragweed sublingual immunotherapy (Greer Laboratories)

Snippet

Sponsor: Greer Laboratories | Conditions: Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2015-01-14